Article
A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models.
Scientific reports - 4 Jun 2021
Daou Nadine, Viader Andreu, Cokol Murat, Nitzel Arianna, Chakravarthy Manu V, Afeyan Raffi, Tramontin Tony, Marukian Svetlana, Hamill Michael J
Abstract excerpt
Nonalcoholic steatohepatitis (NASH) is a complex metabolic disease of heterogeneous and multifactorial pathogenesis that may benefit from coordinated multitargeted interventions. Endogenous metabolic modulators (EMMs) encompass a broad set of molecular families, including amino acids and related metabolites and precursors. EMMs often serve as master regulators and signaling agents for metabolic pathways...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
